Key facts
- This page summarizes Noga Kainan's Form 4 filing for Nano-X Imaging Ltd. (NNOX).
- 1 reported transaction and 3 derivative rows are listed below.
- Accepted by SEC: 29 Jul 2026, 07:35.
Noga Kainan - 28 Jul 2026 Form 4 Insider Report for Nano-X Imaging Ltd. (NNOX)
- Reporting relationship
- Director
- Issuer ticker
- NNOX
- Reported as of
- 28 Jul 2026
- Net transaction value
- +$29,700
- SEC form
- 4
- Accepted by SEC
- 29 Jul 2026, 07:35:41 UTC
- Prior SEC filing
- 19 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Marina Gofman Feler, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Noga Kainan filed Form 4 for Nano-X Imaging Ltd. (NNOX) on 29 Jul 2026.
Change
- Previous filing in this sequence was filed on 19 Mar 2026.
- Current net transaction value: +$29,700.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002049063
Primary reporting owner
Kainan Noga
- Relationship
- Director
- Address
- C/O NANO-X IMAGING LTD., OFER TECH PARK, 94 SHLOMO SHMELTZER ROAD, PETACH TIKVA, ISRAEL
- Signature
- /s/ Marina Gofman Feler, attorney-in-fact
- Signature date
- 29 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NNOX
transaction
Ordinary Shares
Purchase
- Transaction value
- $29,700
- Shares
- +33,000
- Change %
- +424%
- Price
- $0.9000
- Shares after
- 40,792
- Date
- 28 Jul 2026
- Ownership
- Direct
NNOX
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 794
- Date
- 28 Jul 2026
- Ownership
- By: I.B.L. Business Consulting Ltd, a company wholly owned by the reporting person
- Footnotes
- F1
NNOX
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 17,544
- Date
- 28 Jul 2026
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NNOX
holding
Derivative
Stock Option (right to buy ordinary shares)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 12,505
- Date
- 28 Jul 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 12,505
- Exercise price
- $64.61
- Footnotes
- F1, F3
NNOX
holding
Derivative
Stock Option (right to buy ordinary shares)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 50,000
- Date
- 28 Jul 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 50,000
- Exercise price
- $17.63
- Footnotes
- F1, F4
NNOX
holding
Derivative
Stock Option (right to buy ordinary shares)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,000
- Date
- 28 Jul 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 10,000
- Exercise price
- $11.52
- Footnotes
- F1, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
Footnote F2
The ordinary shares reported in this row consist of shares underlying restricted share units that were granted to the Reporting Person on December 10, 2025 and that vest in twelve equal monthly installments such that they will be fully vested upon the one-year anniversary of the grant date.
Footnote F3
The options reported in this row were granted to the Reporting Person by the Issuer on February 9, 2021 and are fully vested and exercisable as of the date of this report.
Footnote F4
The options reported in this row were granted to the Reporting Person by the Issuer on December 28, 2022 and are fully vested and exercisable as of the date of this report.
Footnote F5
The options reported in this row were granted to the Reporting Person by the Issuer on December 31, 2023 and vest and become exercisable in 16 equal installments of 6.25% each on each three-month anniversary of the date of approval of the grant by the Issuer's Board of Directors (i.e., August 14, 2023), such that all options reported in this row will be exercisable on the four-year anniversary of that grant approval date (August 14, 2027).
SEC remarks
Exhibit 24.1 - Power of Attorney